• Integrated Kidney Care of the West, LLC

    KCE Located In: New Mexico and Texas

  • Integrated Kidney Care of the West, LLC

    KCE Located In: New Mexico and Texas

Participant Groups and Providers

AMARILLO NEPHROLOGY ASSOCIATES PA

ADAN GONZALEZ

CHIYYARATH SREENIVASAN

DANIEL HENDRICK

ESTHER IHEUKWUMERE

SHELLY ELAM

EL PASO KIDNEY SPECIALISTS PA

FERNANDO RAUDALES

GERMAN HERNANDEZ

ILEANA MARTINEZ

JAIME GONZALEZ

JORGE SERNA

LAURA HERRERA

MONICA CEPEDA

OSCAR YEE

RAMESH KOMARAGIRI

SIMON RODRIGUEZ

KIDNEY SPECIALISTS OF NEW MEXICO, PC

AMBERLEIGH MORRISH

CHRISTINE CHEN

EDUARDO ALAS

UNIVERSITY OF UTAH HEALTH

MIKLOS MOLNAR

Preferred Groups and Providers

VILLAGEHEALTH DM LLC

ALEXA ACOSTA

ANDRES NIETO

DIANA CORREIA

ELIZABETH OLMOS-CASTANEDA

ESTHER NYARKO

JESSICA MCELHENNY

JESSICA VASIREDDY

JUDITH ROMAN

JULIANA IGE-ODUNUGA

KIMBERLY ELLIS

LAARNI MENDOZA

OLUBUNMI BANJO

SANDRA WATSON

YAIMA MELENDREZ GARCIA

Governing Body Designees

Christine Chen
Kidney Specialists Of New Mexico, Pc

Daniel Hendrick
Amarillo Nephrology Associates Pa

German Hernandez
El Paso Kidney Specialists Pa

TBD
Consumer Advocate

Cay Carner
Davita IKC

Michelle Gressett
Davita IKC

Miklos Molnar
Davita IKC

Clinical and Administrative Leadership

Michelle Gressett
Primary Contact & Administrative Leader
Senior Director, DaVita IKC

Dan Hendrick
KCE Clinical Leader
Amarillo Nephrology Associates Pa

Quality Measures

Information for the following performance measures will be available by February 1st, 2024.

  • The Depression Response measure is a patient-reported outcome measure that assesses the percentage of adult patients (18 years of age or older) who score >9 on the Patient Health Questionnaire (PHQ-9), have a diagnosis of major depression or dysthymia and who demonstrate a response to treatment at approximately 12 months.
  • The Patient Activation Measure (PAM) licensed through Insignia Health (a Phreesia company), assesses the attitudes, motivators, and behaviors that allow a patient to manage his or her healthcare issues. Patient activation is essential to achieving improved health outcomes and cost control.
  • Optimal ESRD Starts quantifies the ability of healthcare providers to prepare patients for ESRD by educating them and their families about the need for dialysis or kidney transplant, helping them to make appropriate and informed choices about their treatment modality, and supporting them in successfully transitioning to dialysis or kidney transplantation as kidney function declines.

Shared Savings and Losses

Information for the following performance measures will be available by February 1st, 2024.

  • Total amount of Shared Savings or Shared Losses per Performance Year
  • Proportion of Shared Savings invested in the program and other resources necessary to improve outcomes and reduce Medicare costs for Beneficiaries
  • Proportion of Shared Savings to KCE Participants and Preferred Providers for each Performance Year

For a full list of facilities and joint ventures, please click here.

For more information on CKCC, click here.